Case report From Diabetes to Neuropathy: A Diagnostic Journey to Leigh Syndrome
Iranian Journal of Child Neurology,
Vol. 19 No. 1 (2025),
7 January 2025
,
Page 113-119
https://doi.org/10.22037/ijcn.v19i1.46085
Abstract
Diabetes is one of the most common chronic disorders in the world, characterized by chronic hyperglycemia. Among the rare causes of diabetes, Leigh syndrome is a rare genetic mitochondrial disorder with unusual manifestations like neurological deficits in addition to typical diabetes symptoms. This report enlightens others about the unusual presentation of diabetes in a pediatric population.
The studied case is a 6-year-old girl with hypothyroidism and diabetes. Post-SARS-CoV-2 infection, she developed progressive lower limb weakness. Magnetic resonance imaging (MRI) and electromyography-nerve conduction velocity (EMG-NCV) revealed brain lesions and polyneuropathy. Genetic testing using whole exome and Sanger sequencing confirmed mitochondrial gene mutations in the MT-NDI location, diagnosing her with Leigh syndrome.
Pediatric diabetic patients typically present with Type 1 diabetes mellitus (T1DM) or Type 2 diabetes mellitus (T2DM), but other causes must be considered. Leigh syndrome can manifest with neurological symptoms, requiring clinicians to recognize its diverse presentations for proper management.
This case highlights the importance of considering rare etiologies for diabetes to improve the prognosis and quality of life.
- Leigh syndrome
- Diabetes
- Neurological disorders
- Mitochondrial disorders
- Genetic testing
How to Cite
References
Craig ME, Hattersley A, Donaghue KC. Definition, epidemiology and classification of diabetes in children and adolescents. Pediatr Diabetes. 2009;10(SUPPL. 12):3–12.
Diagnosis and classification of diabetes mellitus. Vol. 36, Diabetes Care. 2013.
Pucci M, Benati M, Lo Cascio C, Montagnana M, Lippi G. The challenges of diagnosing diabetes in childhood. Diagnosis. 2021;8(3):310–6.
Watson-Fargie T, Marshall V, Fullerton NE, Leach V, Pilz D, Hemingbrough CVY, et al. Leigh syndrome: an adult presentation of a paediatric disease. Pract Neurol. 2023 Aug 11;24(1):45–50.
Yadav AS, Mutanabbi M, Kundu GK, Kawser C. Leigh Syndrome: A Rare Mitrochondrial Disorder. Bangladesh J Child Heal. 2018;41(3):189–92.
Nemoto K, Sano K, Sato S, Maeda Y, Murayama K, Takanashi J ichi. A child with mitochondrial DNA deletion presenting diabetes mellitus as an initial. Radiol Case Reports [Internet]. 2022;17(9):2915–8. Available from: https://doi.org/10.1016/j.radcr.2022.05.061
Chang X, Wu Y, Zhou J, Meng H, Zhang W, Guo J. A meta-analysis and systematic review of Leigh syndrome: Clinical manifestations, respiratory chain enzyme complex deficiency, and gene mutations. Med (United States). 2020;99(5):E18634.
Ramakrishna MP, Pavithran P V., Bhavani N, Kumar H, Nair V, Menon AS, et al. Mitochondrial Diabetes: More Than Just Hyperglycemia. Clin Diabetes. 2019;37(3):298–301.
Tiet MY, Lin Z, Gao F, Jennings MJ, Horvath R. Targeted Therapies for Leigh Syndrome: Systematic Review and Steps towards a “Treatabolome.” J Neuromuscul Dis. 2021;8(6):885–97.
Lin X, Zhou Y, Xue L. Mitochondrial complex I subunit MT-ND1 mutations affect disease progression. Heliyon [Internet]. 2024;10(7):e28808. Available from: https://doi.org/10.1016/j.heliyon.2024.e28808
- Abstract Viewed: 472 times